Diabetic Ulcer Treatment Market Analysis

  • Report ID: 4585
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Diabetic Ulcer Treatment Market Analysis

Ulcer Type (Foot, Mouth, Other Ulcer)

The global diabetic ulcers treatment market is segmented and analyzed for demand and supply by ulcer type into foot ulcer, mouth ulcer, and others. Among these segments, the foot ulcer segment is anticipated to capture the largest market size owing to the rapidly growing number of people around the world who are experiencing diabetic foot ulcers (DFUs). A diabetic foot ulcer is a very serious condition in diabetic patients, as the immunity power and wound healing process are compromised in these people. The wound is even prone to get infectious over time if proper medications are not taken. For instance, every year, it is estimated that 9 to 26 million people around the world suffer from diabetic foot ulcers as a result of their diabetes. There is a significant chance that a diabetic foot ulcer will develop over the course of a patient's lifetime in 16 to 24% of patients with diabetes.

End-user (Hospitals, Clinics, Ambulatory Surgical Centers, Homecare)

The global diabetic ulcers treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and home care. Amongst these segments, the hospitals segment is expected to garner a significant share. The increasing number of hospitals across the world owing to the increasing number of patients suffering from various diseases, and the growing aging population is estimated to propel the growth of the market segment. The increasing favorable reimbursement policies from the government to support people with low income rises the demand for hospitals. The improvement in treatment methods and the presence of experienced doctors in the hospitals is expected to increase the market segment growth in the forecast period. As per the estimations, there are about 8,200 hospitals in Japan as of 2020 and 4,100 hospitals in Korea.

Our in-depth analysis of the diabetic ulcers treatment market includes the following segments:

            By Ulcer Type

  • Foot Ulcer
  • Mouth Ulcer
  • Others

           By Treatment Type

  • Wound-Care Dressings
  • Wound-Care Devices
  • Active Therapies
  • Others

            By End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4585
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diabetic ulcers treatment is estimated at USD 9.41 billion.

The diabetic ulcers treatment market size was valued at USD 8.99 billion in 2024 and is expected to cross USD 18.66 billion by the end of 2037, expanding at more than 5.9% CAGR during the forecast period i.e., between 2025-2037. Rising Prevalence of diabetes, mouth and foot ulcer, increasing medicare spending along with growing cases of gum diseases will boost the market growth.

North America industry is anticipated to dominate largest revenue share by 2037, backed by increasing spending on healthcare along with the presence of key players in the region.

The major players in the market include Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample